Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 6, 2009, Pages 574-579

  Ohbayashi, Hiroyuki ^a,b   Shibata, Naohiro ^a   Hirose, Takashi ^b   Adachi, Mitsuru ^b  

^a Tohno Kousei Hospital   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Asthma; Distal airway; Impulse oscillometry system (IOS); Pranlukast; Salmeterol fluticasone combination (SFC)

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; PRANLUKAST;

ADD ON THERAPY; ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG POTENTIATION; EOSINOPHIL COUNT; FEMALE; HUMAN; LUNG FUNCTION TEST; LUNG RESISTANCE; MALE; OSCILLOMETRY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SPUTUM ANALYSIS;

AGED; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; BRONCHODILATOR AGENTS; CHROMONES; CROSS-OVER STUDIES; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; EMOTIONS; ENVIRONMENT; EOSINOPHILS; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPUTUM;

EID: 71249131928     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.08.002     Document Type: Article

References (26)

1. Ducharme F.M., Lasserson T.J., and Cates C.J. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 4 (2006) CD003137
2. Chapman K.R., Ringdal N., Backer V., Palmqvist M., Saarelainen S., and Briggs M. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Can Respir J 6 (1999) 45-51
3. Ringdal N. Long-acting beta2-agonists or leukotriene receptor antagonists as add-on therapy to inhaled corticosteroids for the treatment of persistent asthma. Drugs 63 Suppl. 2 (2003) 21-33
4. Hamid Q., Song Y., Kotsimbos T.C., Minshall E., Bai T.R., Hegele R.G., et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 100 (1997) 44-51
5. Martin R.J. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol 109 (2002) S447-S460
6. Ohbayashi H., and Adachi M. The evaluation of the distal airway inflammation of well controlled asthmatic patients using sputum induction by inhalation of 10% hypertonic saline for 15 minutes. Arerugi 57 (2008) 1000-1011 [in Japanese]
7. Ohbayashi H. The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation. Jpn J Allergol (Arerugi) 54 (2005) 24-35 [in Japanese]
8. Ohbayashi H., and Adachi M. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with FP in a randomized open double-cross study. Allergol Int 53 (2008) 231-239
9. National Institutes of Health and National heart, lung, and blood institute: global initiative for asthma. Global Strategy for Asthma Management and Prevention; 2002. p. 102-14.
10. Nathan R.A., Sorkness C.A., Kosinski M., Schatz M., Li J.T., Marcus P., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004) 59-65
11. Neito A., Pamies R., Oliver F., Medina A., Caballero L., and Mazon A. Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study). Respir Med 100 (2006) 1180-1185
12. On L.S., Boonyonqsunchai P., Webb S., Davies L., Calverley P.M., and Costello R.W. Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 1320-1325
13. Shiota S., Katoh M., Fujii M., Aoki S., Matsuoka R., and Fukuchi Y. Predictive equations and the reliability of the impulse oscillatory system in Japanese adult subjects. Respirology 10 (2005) 310-315
14. Juniper E.F., Buist A.S., Cox F.M., Ferrie P.J., and King D.R. Validation of a standardized version of the asthma quality of life questionnaire. Chest 115 (1999) 1265-1270
15. Calhoun W.J., Nelson H.S., Nathan R.A., Pepsin P.J., Kalberg C., Emmett A., et al. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone. Am J Respir Crit Care Med 164 (2001) 759-763
16. Pearlman D.S., White M.V., Lieberman A.K., Pepsin P.J., Kalberg C., Emmett A., et al. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma. Ann Allergy Asthma Immunol 88 (2002) 227-235
17. Tomari S., Matsuse H., Hirose H., Tsuchida T., Fukahori S., Fukushima C., et al. Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists. Respiration 76 (2008) 398-402
18. Ramsay CF, Sullivan P, Gizycki M, Wang D, Swern AS, Barnes NC, et al. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial. Respir Med, in press.
19. Fritscher L.G., Rodrigues M.T., Zamel N., and Chapman K.R. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med 103 (2009) 296-300
20. Harrison S., Gatti R., Baraldo S., Oliani K.L., Andre E., Trevisani M., et al. Montelukast inhibits inflammatory responses in small airways of the guinea-pig. Pulm Pharmacol Ther 21 (2008) 317-323
21. Yamaguchi M, Niimi A, Ueda T, et al. Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. Pulm Pharmacol Ther 22, in press.
22. Paggiaro P.L., Chanez P., Holz O., et al. Sputum induction. Eur Respir J 37 (2002) 3s-8s
23. Honda Y., Takahashi H., Kuroki Y., Akino T., and Abe S. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 109 (1996) 1006-1009
24. Betsuyaku T., Kuroki Y., Nagai K., Nasuhara Y., and Nishimura M. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 24 (2004) 964-970
25. Kasper M., Sims G., Koslowski R., Kuss H., Thuemmler M., Fehrenbach H., et al. Increased surfactant protein D in rat airway goblet and Clara cells during ovalbumin-induced allergic airway inflammation. Clin Exp Allergy 32 (2002) 1251-1258
26. Madan T., Kishore U., Shah A., Eggleton P., Strong P., Wang J.Y., et al. Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin Exp Immunol 110 (1997) 241-249